ACT 2 Logo
CONDITION · LOW TESTOSTERONE · RESULTS

When Your Testosterone Comes Back Borderline

It is the most frustrating result to receive and a common one in men who felt well enough to be curious and unwell enough to test. The number sits just under the laboratory's lower limit, or just over it. Either way it does not decide anything, and a man hoping for a verdict is handed a shrug.

The shrug is the correct response to the number alone, and this page explains why — where the threshold comes from, why the same man can land on both sides of it in the same month, and what a clinician who is not trying to sell you something does next.

See if you're eligibleA short, confidential online assessment. Reviewed by a clinician.

What a threshold actually is

A cut-off for low testosterone is not a biological switch. Nothing changes in your physiology as a result crosses it. It is a line drawn across a continuous variable — drawn partly from the bottom of the distribution in healthy young men, and partly from population work asking where in that distribution symptoms start becoming more frequent. Both are statistical exercises, and neither produces a number a body recognizes.

So professional bodies do not all put the line in the same place, and individual laboratories publish different intervals again — partly different analytical methods, partly different source populations. A result described as borderline at one laboratory can be unremarkable at another without anything about the man changing.

"Just below" and "just above" are not two different diagnoses. They are the same finding, described by two laboratories with slightly different habits.

Why the same man lands on both sides

Two sources of variation stack on top of each other, and together they are wide enough to move a borderline result across the line on their own.

Biological variation. Testosterone varies substantially in the same man from one morning to the next, quite apart from illness, sleep, alcohol or training. That is normal physiology, not a measurement problem.

Analytical variation. The assay has its own imprecision, and the routine immunoassays most laboratories run perform least well at the low end of the male range — exactly where a borderline result sits. Mass spectrometry is the more accurate method and is worth asking for when a decision genuinely rests on the number. Both points are covered in getting the test right.

Put those together and a man near the threshold should expect his repeat to land on the other side reasonably often. That is not a contradiction and neither result was wrong. It means the number is not precise enough to carry a decision by itself.

What happens next, in order

A borderline result should start a short, specific sequence rather than a debate.

Repeat it properly. A different morning, fasting, ideally at the same laboratory so the two results are comparable. If the first draw followed a bad week — illness, poor sleep, heavy training, a run of drinking, a recent course of steroids — the repeat is the first result that means anything.

Calculate the available fraction. This is where borderline totals most often resolve, in both directions. Most testosterone in the blood is bound to carrier proteins and unavailable to tissue, and the amount of carrier protein varies with age, weight, thyroid function, liver health and several medications — so a borderline total on a high carrier level can conceal a genuinely low available fraction, and a borderline total on a low carrier level is frequently adequate. See What SHBG Is, and Why It Changes Your Testosterone Result.

Look at the pituitary side. LH and FSH separate a testicular cause from a signaling one, and the distinction changes what the options are — Primary vs Secondary Low Testosterone sets that out. Prolactin gets checked here too.

Work the reversible causes before anything else. This is the step that gets skipped, and in a borderline man it is the step most likely to move the number. Disturbed breathing in sleep, weight, alcohol, mood, thyroid function, and the medication list — see what sleep apnea does to testosterone and medications that lower testosterone. Several of these move testosterone measurably within months.

Then re-measure. A borderline result after those have been addressed is a much more informative number than a borderline result before.

The other half of the diagnosis

The number is one half. The symptom picture is the other, and near the threshold it carries more weight than it does anywhere else.

A borderline result in a man with reduced sexual desire, fewer spontaneous erections and loss of body or facial hair is a stronger case than the same number in a man whose complaints are fatigue, low mood and poor concentration alone — because the second group is so common in men over forty-five that it barely shifts the probability of anything. Is it low T or just aging works through why.

The uncomfortable finding behind all of this is that the relationship between how a man feels and where his number sits is weak. There are men near the bottom of the range who feel entirely well, and men in the comfortable middle who feel terrible. A borderline number is not "half a deficiency" producing half the symptoms. It does not work that way.

About a trial of therapy

Where symptoms are convincing and the number sits near the line, a time-limited trial of treatment is sometimes discussed. It is a legitimate conversation and it deserves an honest account of what it costs.

It is not a reversible experiment in the way it sounds. Testosterone therapy suppresses your own production from the early weeks, and sperm production falls with it — in many men to the point of infertility. Recovery after stopping usually happens but takes months, is not guaranteed, and becomes less likely with longer use. If children are a possibility, that conversation and a male fertility test belong before the trial, not after.

The result is hard to read. Symptoms improve substantially in the placebo arms of testosterone trials. In a single man with no comparison group, feeling better after starting is weaker evidence than it feels like.

It commits you to monitoring, including a red cell measure that is the most common reason therapy gets reduced or paused. Guidance also requires a baseline prostate evaluation and a discussion of your own risk and screening history before treatment, and men with untreated prostate cancer are not candidates — a discussion that belongs with a clinician who knows your history rather than with a web page. Who Should Not Take Testosterone Therapy sets out the full picture.

And it needs an end date agreed in advance. A trial without a defined point at which both sides ask honestly whether anything changed is not a trial — it is a prescription that renews itself. If nothing has changed after a fair period, the honest answer is to stop. Still Tired on Testosterone Therapy and Do You Have to Stay on Testosterone Therapy Forever? are the two worth reading first.

Where the picture is a secondary one, stimulating your own production is the other route and does not carry the same suppression. It also does less, less predictably, and only where the testes can respond — Testosterone Therapy or Enclomiphene compares them.

[ Get measured properly → ]

Questions

Frequently asked questions

  • Not on that basis alone. A threshold is a statistical line across a continuous variable, societies and laboratories place it slightly differently, and day-to-day plus assay variation is wide enough to move a borderline result across it. It needs a properly taken repeat, the available fraction calculated, and a matching symptom picture.

  • Both, probably. That is the expected behavior of a number that varies day to day, measured by an assay with its own imprecision, in a man sitting near the line. It tells you the number cannot carry the decision by itself.

  • For a borderline total, yes — calculated from total testosterone, the carrier protein and albumin rather than measured directly. It is where borderline results most often resolve, in either direction.

  • It is a conversation some clinicians will have, but it is not a neutral experiment. Therapy suppresses your own production and sperm production from the early weeks, recovery takes months and is not guaranteed, and improvement in a single person is hard to distinguish from what happens in placebo groups. If it is done, it needs a defined end point agreed at the start.

  • Then the reversible causes are where the value is — sleep, weight, alcohol, mood, thyroid, medications — followed by a repeat measurement. Several of those move testosterone measurably, and all of them move the symptoms.

  • Often, yes — but not passively. Retesting after addressing sleep, alcohol, weight and the medication list produces a far more useful number than retesting after three months of nothing changing.

Your next step

Where this fits in your plan

A borderline result is not half an answer. It is an instruction to do the other half of the work: repeat the draw properly, calculate the available fraction, check the pituitary side, and deal with the reversible causes before anyone reaches for a prescription.

For a good number of men at this point the conclusion is not yet, and that is a real clinical decision rather than a failure to get treated. If the picture does become clear, how testosterone therapy is actually run here is the next page. If the number keeps coming back unremarkable and you still feel wrong, When Every Lab Is Normal and You Still Feel Wrong and the other causes of fatigue are where the search goes.

We measure first. Then we act.

References

  1. Bhasin S et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline — diagnostic thresholds, confirmatory testing, free testosterone, and baseline prostate and hematologic assessment.
  2. American Urological Association. Testosterone Deficiency: AUA Guideline — diagnosis, and evaluation before treatment.
  3. Testosterone products — FDA-approved prescribing information, Warnings and Precautions.
  4. U.S. Food and Drug Administration. Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging.

How we write and review our content

ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.

Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.

A borderline testosterone result is not a diagnosis and does not by itself indicate treatment. Testosterone therapy suppresses the body's own production and sperm production, requires ongoing monitoring, and is prescribed only after clinical evaluation.

We measure first. Then we act.

Start with a baseline that reads your history, not only your labs.